Modeling neurodegeneration in Caenorhabditis elegans

Kim A. Caldwell, Corey W. Willicott, Guy A. Caldwell

Modeling neurodegeneration in Caenorhabditiselegans. Dis Model Mech 1 October 2020; 13 (10): dmm046110. doi:

Drug discovery: Insights from the invertebrate Caenorhabditis elegans

Giunti S, Andersen N, Rayes D, De Rosa MJ.

Drug discovery: Insights from the invertebrate Caenorhabditis elegans. Pharmacol Res Perspect. 2021 Apr;9(2):e00721. doi:

Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

Peter A. Kropp, Rosemary Bauer, Isabella Zafra, Carina Graham, Andy Golden

Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths. Dis Model Mech 1 August 2021; 14 (8): dmm049010. doi:

Editorial: C. elegans as an emerging model of pharmacological innovation

Huang Z, Ma L, Mishra A, Turnbull JE, Tu H.

Editorial: C. elegans as an emerging model of pharmacological innovation. Front Pharmacol. 2022 Sep 27;13:1029752. doi: